Disclosures

Paid Consultant for Geitlisch Pharma
Stock received from Regeneration Technologies, Inc.
Board of Directors member for American Orthopaedic Society for Sports Medicine
All relevant financial disclosures have been mitigated.
Disclosures complete: May 23, 2024